Latest News about Ibogaine
Recent news which mentions Ibogaine
From Benzinga
At 77, Cannabis Champion Dana Beal Fights Idaho Laws To Push Legalization In Hostile Territory
March 26, 2024
Tickers
NEWS
From Benzinga
Cannabis Crusader Dana Beal's Incarceration: A Blow To Legalization Advocacy And Psychedelic Policy Reform
January 25, 2024
From Benzinga
Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More
January 07, 2024
From Benzinga
This Maine City Moves Unanimously On Decriminalizing Psychedelics: Focus On Public Health
September 25, 2023
From Benzinga
From Benzinga
African Iboga Root Heads To Canadian Company Developing Natural Drugs To Help Treat Addictions
May 17, 2023
Tickers
FLHLF
From Benzinga
EXCLUSIVE: Ibogaine Therapy Co. Bienstar On Successful Addiction Treatment, Global Market & Future Prospects
April 27, 2023
From Benzinga
Psychedelics Update: MDMA Export, 3D Farm, Recovery Center Reopens, Mushroom Extraction & E-Commerce
January 24, 2023
From Benzinga
Ibogaine To Treat Addiction: 5 Reasons Why It's Safer To Do It In Hospital Settings
November 21, 2022
From Benzinga
Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!
April 06, 2022
From Benzinga
What Is Iboga And How Does It Compare To Cannabis, Exactly?
April 02, 2022
From Benzinga
Are Psychedelics Starting to Emerge as Legitimate Therapies?
January 19, 2022
From Stock Gumshoe
National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000
December 08, 2021
From Benzinga
Novamind Partners With Bienstar Wellness, Opening Door To Ibogaine Treatment For Addiction Disorders
December 02, 2021
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.